This is a preview of subscription content, log in to check access.
Buy single article
Instant access to the full article PDF.
Price includes VAT for USA
GE Healthcare.Study shows GE Healthcare's VisipaqueTM Associated with Lower Incidence of Contrast-Induced Nephropathy and Cardiovascular Events in Patients with Chronic Kidney Disease Compared to Iopromide. Media Release: 22 Nov 2008. Available from: URL: http://www.gehealthcare.com
About this article
Cite this article
Fewer CV events, less nephropathy with iodixanol vs iopromide. React. Wkly. 1230, 2 (2008). https://doi.org/10.2165/00128415-200812300-00004
- Chronic Kidney Disease
- Image Quality
- Kidney Disease
- Contrast Agent